Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Industry Trends
Industry Trends
Employers, Health Plans, and New Drug Benefit Designs: A Shifting Landscape
Mark Zitter, MBA
,
Michael Snyder
Play Video
Industry Trends
Enhanced Generic Utilization Saved US Healthcare $139.6 Billion in 2009
Dalia Buffery, MA, ABD
Play Video
Industry Trends
FDA Bolsters Its Generic Approval Process: Health Plans Reap the Benefits
Play Video
Industry Trends
FDA Commissioner Outlines New Plan to Increase Biosimilars by Balancing Innovation and Competition
Eileen Koutnik-Fotopoulos
Eileen Koutnik-Fotopoulos
Play Video
Industry Trends
FDA’s Approval Process Borne Out by a Large Study: But Communicating Generics’ Safety and Efficacy to the Public Leaves Much to Be Desired
Dalia Buffery, MA, ABD
Play Video
Industry Trends
First Anti-Inflammatory Generic Drug Promising New Therapy for Diabetes
Dalia Buffery, MA, ABD
Play Video
Industry Trends
First Generic ARB Approval Draws a Wave of Comparative Studies
Dalia Buffery, MA, ABD
Play Video
Industry Trends
Focus on Lowest Net Cost Drug Reduces Costs for Patients, Plan Sponsors
Dana H. Felthouse, MBA
Play Video
Industry Trends
Generics “Pipeline” Predicts Continued Market Share Gains Through 2014
Dalia Buffery, MA, ABD
Play Video
Industry Trends
Global Issues Driving US Healthcare Trends in 2021 and 2022
F. Randy Vogenberg, PhD, FASHP
,
John Santilli, MBA
F. Randy Vogenberg, PhD; John Santilli, MBA
Play Video
1
2
3
4
5
6
Page 3 of 8
Results 21 - 30 of 77